한글목차

펜타닐 동향 및 전망

세계 펜타닐 시장은 2024년부터 2030년까지 연평균 6.2%의 성장률을 보일 것으로 예상됩니다. 이 시장의 주요 촉진요인은 전 세계 고령화율 증가, 암 이환율 증가, 종양학에 대한 지출 증가입니다. 세계 펜타닐 시장의 미래는 병원, 종양 센터 및 수술 센터 시장에서의 기회로 인해 유망한 것으로 보입니다.

• Lucintel은 투여 경로 카테고리에서 경구용 필름이 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상했습니다.
• 최종 용도 부문에서는 암 진단을 받는 환자 수가 증가함에 따라 종양 센터가 가장 큰 부문으로 남을 것으로 보입니다.
• 지역별로는 북미가 인구 증가와 연구 노력, 다양한 암 진단을 포괄하는 건강 보험으로 인해 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

펜타닐 시장의 전략적 성장 기회

펜타닐 시장에는 약물 투여 기술 발전, 의료 요구 사항의 변화, 산업 규정 및 규제 변화 등에 힘입어 다양한 응용 분야에 걸쳐 몇 가지 전략적 성장 기회가 있습니다. 펜타닐 사용과 관련된 과제를 해결하면서 이 시장 내 동향을 활용하고자 하는 이해관계자들은 이러한 동향을 제대로 파악하고 적절히 활용하는 것이 중요합니다.

• 남용 억제제 개발 : 펜타닐 시장의 성장은 남용 억제제 개발로 인해 크게 확대될 수 있습니다. 이러한 제제는 약물에 대한 간섭과 남용을 어렵게 만들어 오용과 중독을 줄이기 위해 만들어집니다. 예를 들어, 서방형 패치나 펜타닐이 통증 치료에 효과적이라는 것을 보장하면서 나록손을 혼합한 제품 등이 개발될 수 있습니다. 이러한 제형에 대한 관심은 오피오이드 남용에 대한 우려를 인식한 규제 동향에 따른 것입니다.
• 통증 관리 솔루션의 확대 : 통증 관리 솔루션의 확대는 펜타닐 시장의 주요 성장 분야 중 하나입니다. 효율적인 통증 관리에 대한 수요가 증가함에 따라 효율성과 안전성을 향상시킬 수 있는 첨단 펜타닐 제형과 전달 시스템이 요구되고 있습니다. 따라서 기업들은 의료 서비스 제공자의 요구에 따라 개별화된 통증 관리 계획이나 다양한 환자 범주를 대상으로 하는 병용 약물과 같은 다른 용도로 진출할 수 있습니다. 이러한 성장 기회는 환자 예후 개선과 만성 통증 관리에 대한 관심이 높아지는 추세와 맞물려 있습니다.
• 나록손 접근성 확대 : 나록손에 대한 접근성 확대는 펜타닐 시장에서 전략적 성장 기회로 작용하고 있습니다. 나록손(과다복용 회복을 위한 오피오이드 길항제)의 접근성을 확대하는 것은 오피오이드 위기가 전 세계 지역사회에 계속 영향을 미치고 있고, 해결의 실마리가 보이지 않기 때문에 반드시 필요합니다. 오늘날의 세계는 앞으로 이 문제에 대처하기 위해 더 나은 대비가 요구되고 있습니다. 그 결과, 기업들은 나록손의 광범위한 배포를 목표로 하는 프로그램에 더 많은 투자를 할 수 있을 것으로 보입니다. 공중 보건 기관과의 파트너십과 이 제품을 더 쉽게 이용할 수 있도록 하는 새로운 방법은 이 성장 단계에 진입을 촉진하고 관련 보건 이니셔티브는 과다 복용을 보다 효과적으로 예방할 수 있는 수단을 창출할 수 있을 것으로 보입니다.
• 신흥 시장 성장 : 펜타닐 시장은 신흥국 시장의 급속한 발전으로 인해 큰 기회를 맞이하고 있습니다. 특히 아시아태평양과 라틴아메리카에서 통증 관리에 대한 사람들의 인식이 높아짐에 따라 의료 인프라가 개선되고 펜타닐 및 기타 오피오이드에 대한 수요가 증가할 것입니다. 기업은 유통 채널을 구축하고, 제품을 현지화하고, 규제 프레임워크를 이해함으로써 이들 시장에 진출할 수 있습니다. 이러한 성장 기회는 빠르게 발전하는 지역에서 수익과 시장 입지를 높일 수 있는 잠재력을 가지고 있습니다.
• 디지털 헬스 솔루션의 발전 : 펜타닐 시장에는 디지털 헬스 솔루션 개발로 인한 성장 기회가 존재합니다. 원격의료, 모바일 건강 앱, 모니터링 시스템과 같은 디지털 기술의 통합은 통증 관리와 오피오이드 관리를 향상시킬 수 있습니다. 이러한 기술은 특정 치료 서비스를 제공하고, 환자의 약물 복용률을 높이며, 치료 후 환자 결과를 추적하는 데 활용될 수 있습니다. 이러한 성장 기회는 디지털 헬스(digital health)로 향하는 추세와 맞물려 펜타닐 사용 관리의 혁신 가능성을 제공합니다.

이러한 전략적 성장 기회는 혁신을 촉진하고, 시장 범위를 확장하며, 진화하는 의료 수요에 대응함으로써 펜타닐 시장의 전망을 재구성하고 있습니다. 펜타닐과 관련된 통증 관리 문제를 해결하기 위해 보다 안전하고 효과적인 치료제를 개발할 수 있도록 지원함으로써 기업은 경쟁 우위를 확보할 수 있습니다.

펜타닐 시장의 촉진요인 및 과제

펜타닐 시장은 성장과 개척을 형성하는 다양한 촉진요인과 도전에 영향을 받고 있습니다. 주요 촉진요인으로는 기술 발전, 경제적 요인, 규제 변경 등이 있으며, 중요한 도전 과제에는 규제 준수, 시장 내 경쟁, 사용 재료와 관련된 제한 등이 있습니다. 이 복잡한 약물군별 거래의 이해관계자들은 이러한 역학관계를 이해하는 것이 중요합니다.

펜타닐 시장을 주도하는 요인은 다음과 같습니다.

1. 기술 발전 : 펜타닐 시장의 성장은 주로 기술 개척에 의해 이루어짐. 남용 억제제 및 서방형 패치와 같은 약물전달 시스템의 혁신은 펜타닐의 안전성과 효능을 향상시킵니다. 이러한 발전은 환자의 통증 관리를 강화하는 동시에 중독 사례와 오남용을 줄이는 것을 목표로 합니다. 기술에 투자하는 기업은 차별화된 제품을 제공함으로써 역동적인 시장 동향에 적응하고 펜타닐 시장에서 경쟁 우위를 확보할 수 있습니다.

2. 통증 관리에 대한 수요 증가 : 통증 관리에 대한 수요가 크게 증가하면서 펜타닐 시장을 주도하고 있습니다. 만성 통증 질환의 유병률이 증가함에 따라 펜타닐과 같은 통증 완화를 위한 효과적인 솔루션이 요구되고 있습니다. 이러한 수요의 배경에는 60세 이상 인구의 증가, 의료 치료법의 발전, 다양한 통증 관리 전략에 대한 인식 등이 있습니다. 그 결과, 통증 조절에 대한 필요성이 증가하면서 펜타닐에 대한 수요가 증가하여 시장 규모 확대에 기여하고 있습니다.

3. 안전한 사용을 위한 규제 지원 : 전 세계 여러 정부에서 펜타닐의 안전한 사용을 위해 규제 당국의 지원을 인정하고 있으며, 이는 시장 내 확산으로 이어지고 있습니다. 예를 들어, 새로운 형태의 의약품을 승인하거나 일반적인 연간 또는 월별 처방 관행을 모니터링하는 방식으로 이를 시행하고 있습니다. 이러한 규제는 궁극적으로 중독으로 이어질 수 있는 남용으로부터 시민들을 보호하는 동시에 의사가 의학적으로 필요할 때마다 펜타닐을 이용할 수 있도록 보장합니다. 안전한 사용 측면에서 이러한 정책은 오피오이드 위기에 대응하고 환자 치료를 개선하려는 광범위한 노력과 일치합니다.

4. 헬스케어 접근성 확대 : 세계 헬스케어 부문의 성장률은 펜타닐 관련 부문을 포함하여 이 산업 내 세분화된 부문의 전체 매출을 이끄는 주요 원동력 중 하나로 부상하고 있습니다(Tyler et al.) 그 결과, 세계 헬스케어 시설의 증가, 특히 펜타닐을 포함한 다양한 종류의 통증 관리를 받을 수 있는 환자의 증가를 의미합니다. 이러한 확대는 주로 신흥 시장에서 일어나고 있는데, 이는 의료 서비스에 대한 접근성이 향상되고 사람들이 오피오이드 약물의 필요성에 대해 더 많은 정보를 얻게 되었기 때문입니다. 의료 서비스 접근성 확대는 펜타닐의 광범위한 보급에 기여하고 시장 개척을 지원하고 있습니다.

5. 공중보건에 대한 관심 : 공중보건에 대한 관심은 펜타닐 시장에 큰 영향을 미치고 있습니다. 예를 들어, 나록손의 적용 범위 확대 및 유해 물질 감소 프로그램과 같은 시책은 이 산업을 재편하는 데 중요한 역할을 하고 있습니다. 이러한 이니셔티브는 주로 환자의 회복률을 높이는 동시에 오피오이드 사용으로 인한 부작용을 최소화하는 것을 목표로 하고 있습니다. 기업이 이러한 이니셔티브에 참여함으로써 시장에서의 입지를 강화하는 동시에 전반적인 건강 목표를 달성할 수 있습니다.

펜타닐 시장의 도전 과제는 다음과 같습니다.

1. 규제 준수 : 규제 준수는 펜타닐 시장에서 사업을 영위하는 기업에게 중요한 과제입니다. 따라서 제품의 유효성과 안전성을 보장하기 위해 엄격한 규정과 가이드라인을 준수해야 합니다. 끊임없이 변화하는 규정을 준수하는 것은 매우 어렵고 비용이 많이 들며, 제품 개발 프로세스를 복잡하게 만들고 특정 시장에 대한 접근을 제한할 수 있습니다. 법적 문제를 피하기 위해 기업은 규제에 대한 전문 지식을 갖추고 시장 점유율을 유지하기 위해 제품이 적용되는 모든 기준을 충족하는지 확인해야 합니다.

2. 시장 경쟁 : 펜타닐 분야에서 높은 경쟁 수준은 기업이 직면한 큰 도전 중 하나입니다. 유사한 제품을 제조하는 여러 기업이 큰 경쟁을 일으켜 가격 하락 압력으로 이어집니다. 따라서 기업은 경쟁력을 유지하기 위해 강력한 마케팅 전략과 함께 고품질 제품을 생산하는 혁신적인 아이디어를 개발하여 경쟁력을 유지해야 합니다. 이러한 경쟁에 대처하는 것은 미래의 세계 고객 기반을 확장하고 현재 시장에서 성공하고자 하는 기업에게 필수적입니다.

3. 재료의 한계 : 펜타닐 제품의 성능은 재료의 제약과 특정 제형의 효율성 및 안전성과 같은 요인에 따라 달라집니다. 이러한 제품의 성공을 제한할 수 있는 문제에는 제한된 효능, 잠재적인 부작용, 장기적인 진통 효과의 문제 등이 있습니다. 이러한 제약조건을 극복하기 위해서는 제품의 품질을 향상시키고 고객의 기대에 부응하기 위한 기업별 연구개발이 이루어져야 합니다.

펜타닐 시장의 복잡성은 펜타닐 시장에 영향을 미치는 촉진요인과 도전과제로 인해 더욱 부각되고 있습니다. 기술 발전, 통증 관리에 대한 수요 증가, 규제 지원은 성장을 촉진하는 반면, 규제 준수, 시장 경쟁 및 재료 제한은 큰 도전이 될 수 있습니다. 펜타닐 분야의 기업들은 장기적인 성공을 위해 이러한 요인들을 해결하기 위해 노력해야 합니다.

목차

제1장 주요 요약

제2장 세계의 펜타닐 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 펜타닐 시장 동향(2018-2023년)과 예측(2024-2030년)
• 투여 경로별 : 펜타닐 세계 시장
  • 설하정
  • 버칼정
  • 구강 필름
  • 기타
• 최종 용도별 : 펜타닐 세계 시장
  • 병원
  • 종양학 센터
  • 외과 센터
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 펜타닐 세계 시장
• 북미의 펜타닐 시장
• 유럽의 펜타닐 시장
• 아시아태평양의 펜타닐 시장
• 기타 지역의 펜타닐 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 투여 경로별 : 세계의 펜타닐 시장 성장 기회
  • 최종 용도별 : 세계의 펜타닐 시장 성장 기회
  • 지역별 : 세계의 펜타닐 시장 성장 기회
• 세계의 펜타닐 시장 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 펜타닐 시장 생산능력 확대
  • 세계의 펜타닐 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Bayer
• Novartis
• Sanofi-Aventis Groupe
• Abbott Laboratories
• Merck & Co
• Validus Pharmaceuticals
• Teva Pharmaceutical Industries

영문목차

Fentanyl Trends and Forecast

The future of the global fentanyl market looks promising with opportunities in the hospital, oncology center, and surgical center markets. The global fentanyl market is expected to grow with a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are the rising aging population globally, increasing incidences of cancer, and rising oncology spending.

• Lucintel forecasts that, within the route of administration category, oral film is expected to witness the highest growth over the forecast period.
• Within the end-use category, the oncology center will remain the largest segment due to the rising number of individuals diagnosed with cancer.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to increasing population and research endeavors, coupled with health insurance encompassing diverse cancer diagnoses.

Gain valuable insight for your business decisions with our comprehensive 150+ page report

Emerging Trends in the Fentanyl Market

Several emerging trends in the fentanyl market are indicative of larger regulatory, technological, and social shifts. How fentanyl is developed, distributed, and managed is being shaped by these patterns, which also have significant implications for both medical and illicit use. Grasping these developments becomes vital for stakeholders who wish to navigate this shifting landscape of fentanyl markets.

• Enhanced Regulatory Measures: Increasing concerns regarding addiction and misuse are driving enhanced regulatory measures within the fentanyl market. The opioid crisis has led governments around the world to tighten control over the production, distribution, and prescription of fentanyl. These measures include stricter prescription practices, better tracking systems, and sterner penalties against illegal trafficking. Such steps aim to strike a balance between effective pain management on one hand and the prevention of misuse leading to abuse on the other.
• Innovations in Drug Delivery Systems: The fentanyl market is being transformed through innovations in drug delivery systems. For instance, extended-release patches and abuse-deterrent formulations under development are expected to increase safety levels and effectiveness of new fentanyl products. These advances reduce addiction risks while simultaneously improving pain management among patients. Thus, changes in drug delivery technology are expected to significantly influence the future dynamics of fentanyl treatment and its market.
• Growing Focus on Naloxone Availability: There is an increasing emphasis on boosting naloxone availability (an opioid antagonist used to reverse overdoses). This expansion addresses several issues related to opioids, particularly counterfeit drugs made from fentanyl, by responding to the ongoing global opioid crisis. Public health programs are implementing policies to introduce naloxone to first responders, including healthcare providers and those at risk of overdose, making it more accessible. This matters since it can address public health impacts associated with opioid use beyond just those caused by fentanyl.
• Expansion of Harm Reduction Strategies: Harm reduction strategies are becoming more prevalent in the fentanyl market as part of a broader approach to addressing the opioid crisis. These measures include using fentanyl testing strips, supervised injection facilities, and needle exchanges. The aim is to reduce the adverse health outcomes associated with opioid use, including that involving fentanyl, and to provide assistance and resources for people fighting addiction. Thus, by expanding harm reduction strategies, we can see a shift towards more compassionate, public health-focused approaches.
• Increased International Collaboration: Notably, there is increased international collaboration in the fentanyl market. Countries are partnering to address global threats arising from fentanyl and other synthetic opioids. This involves sharing intelligence on trafficking networks, harmonizing regulatory frameworks, and coordinating public health responses, among other actions. International cooperation is essential to effectively address the complications associated with fentanyl, ensuring effective management of its use and prevention of abuse.

These emerging trends have changed the face of the fentanyl market through regulatory practices, technological innovations, and public health approaches. Therefore, stakeholders need to adjust accordingly, as these trends will help them meet the challenges they face in dealing with fentanyl in society today, which is continually evolving.

Recent Developments in the Fentanyl Market

Technological advances, policy changes, and healthcare reforms have all played a major role in the recent developments witnessed in the fentanyl market. They are changing how fentanyl is used for medical purposes and its contribution to the opioid epidemic. Understanding these critical developments helps us understand how this market has been responding to new challenges and opportunities.

• The New Stringent Regulation Rules: Governments from around the world are introducing stricter regulations on fentanyl as part of efforts aimed at fighting the opioid crisis. This includes tightening prescription regulations, increasing monitoring of prescribing practices, and imposing stiffer penalties for illegal trafficking of such drugs. These measures aim to reduce misuse and abuse while ensuring that fentanyl remains available for legitimate medical use. Stricter controls also influence market dynamics regarding the prescribing and distribution of fentanyl.
• Introduction of Abuse-Proof Formulations: The introduction of abuse-resistant formulations is a major development seen in the fentanyl market. These formulations aim to make it more difficult for people to tamper with or abuse fentanyl, thus reducing the chances of addiction or misuse. Examples include extended-release patches and naloxone combination products, which have been introduced to ensure the safe use of fentanyl while still serving as effective painkillers. These trends will shape future usage patterns associated with fentanyl and alleviate concerns regarding opioid dependency issues.
• Expansion of Harm Reduction Initiatives: As part of a broader strategy to address the opioid crisis, harm reduction initiatives are increasing. They include wider use of naloxone, employing fentanyl test strips, and establishing supervised injection sites, such as in Vancouver, where about 4 million prescriptions were written last year alone (Syringe Distribution Program). Such initiatives aim to mitigate risks connected with opioids, including those containing fentanyl, while also supporting those struggling with addiction and related problems. Increasingly, harm reduction is adopting a comprehensive approach to managing opioid-related concerns.
• International Cooperation as a Priority: International cooperation in the fentanyl market is becoming more important as countries strive to address the global challenges posed by synthetic opioids. Their joint efforts include sharing information about trafficking networks, harmonizing regulatory approaches, and synchronizing public health systems, among others. An increased focus on international cooperation is indispensable given the complexities associated with fentanyl and the need for effective strategies for its management and control.
• Innovations in Pain Management Research: The market for fentanyl is influenced by pain management research, which explores new indications and formulations for the drug. The goal of these studies is to improve efficacy and safety through fentanyl's use in pain management, as well as to find alternatives such as novel delivery systems or combination therapies that could be employed alongside it. These efforts seek to improve patient outcomes by addressing the challenges posed by opioids. Continued emphasis on R&D is fostering innovation in the fentanyl market, leading to better results in pain management.

Consequently, these recent developments have influenced regulatory practices, technological innovations, and public health strategies shaping the fentanyl market. Stakeholders must therefore navigate these transformations, even if the price may be too high, considering how this substance has affected our community today.

Strategic Growth Opportunities for Fentanyl Market

The fentanyl market has several strategic growth opportunities across various applications driven by technological advancements in drug administration, changing healthcare requirements, and shifts in industry rules and regulations. It is important for stakeholders who want to take advantage of trends within this marketplace while dealing with challenges associated with fentanyl usage to identify these trends correctly and capitalize on them appropriately.

• Abuse-Deterrent Formulations Development: Fentanyl market growth can be greatly expanded through the development of abuse-deterrent formulations. These formulations are created to reduce misuse and addiction by making it harder for the drug to be interfered with or abused. For example, companies can develop products such as extended-release patches and those that combine naloxone while ensuring that fentanyl remains effective in pain treatment. The focus on such formulations aligns with regulatory trends and acknowledges concerns about opioid abuse.
• Pain Management Solutions Expansion: The expansion of pain management solutions forms one of the key areas of growth in the fentanyl market. Given the increasing demand for efficient pain management, there is a need for advanced fentanyl formulations and delivery systems that guarantee enhanced efficiency and safety. Hence, businesses could delve into other applications like personalized pain management plans and combined medications targeting different patient categories, in line with healthcare providers' requirements. This growth opportunity aligns with the increasing focus on improving patient outcomes and managing chronic pain.
• More Naloxone Access: Increased access to naloxone offers a strategic growth opportunity within the fentanyl market. Expanding the availability of naloxone (an opioid antagonist used for reversing overdoses) is necessary because the opioid crisis continues to affect communities globally, with no relief in sight. Today's world requires better preparedness to deal with this problem going forward. Consequently, companies could invest more in programs aimed at distributing naloxone widely; partnerships with public health organizations and novel methods to make this product more accessible would facilitate entry into this growth stage, where associated health initiatives will create a means for preventing overdoses more effectively.
• Emerging Markets Growth: The fentanyl market has great opportunities due to the rapid development rates of emerging markets. As awareness of pain management increases among people, especially across Asia-Pacific regions and Latin America, the healthcare infrastructure will improve, leading to greater demand for fentanyl and other opioids. Businesses can expand into these markets by creating distribution channels, localizing products, and understanding regulatory frameworks. This growth opportunity offers potential for increased revenue and market presence in rapidly developing regions.
• Digital Health Solutions Advancements: Growth opportunities exist in the fentanyl market through the development of digital health solutions. The integration of digital technologies such as telemedicine, mobile health apps, and monitoring systems could enhance pain management and opioid control. These technologies can be used to offer specific care services, improve medication adherence rates among patients, and track patient outcomes after treatment. This growth opportunity aligns with the increasing trend towards digital health and offers potential for innovation in the management of fentanyl use.

By fostering innovation, expanding market reach, and meeting evolving healthcare needs, these strategic growth opportunities are reshaping the fentanyl market landscape. They can help companies gain a competitive advantage by supporting the creation of safer and more effective remedies aimed at addressing pain management issues related to fentanyl.

Fentanyl Market Driver and Challenges

The fentanyl market is influenced by various drivers and challenges that shape its growth and development. Key drivers include technological advancements, economic factors, and regulatory changes, whereas significant challenges consist of compliance with regulations, competition within markets, and limitations associated with materials used. For stakeholders within the complex field of this drug class trade, it's important to understand these dynamics.

The factors responsible for driving the fentanyl market include:

1. Technological Advancements: Fentanyl market growth is mainly driven by technological developments. Innovations in drug delivery systems, such as abuse-deterrent formulations and extended-release patches, improve the safety and effectiveness of fentanyl. These advances aim to mitigate addiction cases and misuse while also enhancing pain management among patients. Companies that invest in technology will be able to offer differentiated products, thereby adjusting to dynamic market trends and gaining a competitive advantage within the fentanyl market.

2. Increasing Demand for Pain Management: There is a significant rise in demand for pain management driving the fentanyl market. With the increased prevalence of chronic pain conditions, there is a need for effective solutions for pain relief, such as fentanyl. Factors behind this demand include an increase in the population aged over 60 years, advancements in medical treatment methods, and awareness of different pain management strategies. As a result, the need for fentanyl grows with the increasing requirement for pain control, contributing to the expansion of the market size.

3. Regulatory Support for Safe Use: Regulatory support has been recognized across various governments worldwide regarding the safe use of fentanyl, leading to its expansion within the marketplace. For instance, they do this by approving new forms of drugs and monitoring prescription practices on a typical yearly or monthly basis. Such regulations assure citizens of protection from abuse, which ultimately leads to addiction, while ensuring that doctors still have access to it whenever it's medically needed. In the context of safe use, these policies coincide with broader efforts aimed at addressing the opioid crisis and improving patient care.

4. Expansion of Access to Healthcare: The growth rate of the global healthcare sector has emerged as one of the principal drivers propelling sales across subdivisions within this industry, including those relating to fentanyl (Tyler et al., 2016). Consequently, increasing healthcare facilities globally signify that there are more patients who can receive various types of pain management, especially involving fentanyl. This expansion is mainly taking place in emerging markets as accessibility to healthcare improves and people become more informed regarding the need for opioid drugs. The growth in healthcare access contributes to the broader adoption of fentanyl and supports market development.

5. Focus on Public Health Initiatives: Public health initiatives have greatly impacted the fentanyl market. For example, measures such as increasing naloxone coverage and harm reduction programs have played a critical role in reshaping this industry. Primarily, these initiatives aim to minimize the negative implications that come with opioid use while improving patient recovery rates. The involvement of business enterprises with such initiatives can enhance their presence within the market while aligning with overall health goals.

Challenges in the fentanyl market include:

1. Regulatory Compliance: Regulatory compliance is a significant challenge for players operating within the fentanyl market. This requires adherence to a number of strict rules and guidelines meant to ensure product effectiveness and safety. Ensuring compliance with constantly changing regulations can be very difficult and expensive, complicating product development processes and limiting access to particular markets. To avoid legal issues, companies must possess regulatory expertise and ensure their products align with all applicable standards to maintain market share.

2. Market Competition: In the fentanyl sector, high competition levels are one of the major challenges that firms face. Different companies manufacturing similar products generate significant competition, leading to downward pressure on prices. Firms must therefore develop innovative ideas resulting in quality products coupled with strong marketing strategies to remain competitive. Addressing these competitive forces is essential for any firm looking to expand its future global customer base or succeed within its current markets.

3. Material Limitations: The performance of fentanyl products depends on factors such as material constraints and the efficiency and safety of specific formulations. Issues that can limit the success of such products include limited effectiveness, potential side effects, and challenges with long-lasting pain relief. Research and development must be conducted by businesses to improve product quality and meet customer expectations in order to overcome these limitations.

The complexity of the industry is highlighted by the drivers and challenges affecting the fentanyl market. Technological advancements, increasing demand for pain management, and regulatory support drive growth, while regulatory compliance, market competition, and material limitations pose significant challenges. Companies in the fentanyl sector should endeavor to address these factors for long-term success in this industry.

List of Fentanyl Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies fentanyl companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the fentanyl companies profiled in this report include-

• Bayer
• Novartis
• Sanofi-Aventis Groupe
• Abbott Laboratories
• Merck & Co
• Validus Pharmaceuticals
• Teva Pharmaceutical Industries

Fentanyl by Segment

The study includes a forecast for the global fentanyl by route of administration, end use, and region.

Fentanyl Market by Route of Administration [Analysis by Value from 2018 to 2030]:

• Sublingual Tablet
• Buccal Tablet
• Oral Film
• Others

Fentanyl Market by End Use [Analysis by Value from 2018 to 2030]:

• Hospital
• Oncology Centers
• Surgical Centers
• Others

Fentanyl Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Fentanyl Market

The fentanyl market is changing significantly as regulation evolves, demand for pain management increases, and drug abuse and trafficking continue to pose challenges. Fentanyl is a powerful synthetic opioid that plays a vital role in medical practice and illicit use. Market trends are responding to policy changes, innovations in drug delivery systems, and strategies aimed at addressing the ongoing opioid crisis. This knowledge is important as it will help stakeholders navigate the complexities of the fentanyl market across various regions.

• United States: Fentanyl in the U.S. market is significantly affected by the opioid epidemic, which has attracted massive regulatory reforms and public health interventions. Recently, there has been stricter regulation on prescription opioids, along with increased efforts against illegal fentanyl trafficking. New formulations of fentanyl have been approved by the U.S. FDA to improve their safety profile and limit the potential for misuse. Moreover, significant attention has been given to naloxone access programs and other harm reduction initiatives for reversing overdose cases. Similarly, the availability of fentanyl test strips for detecting this substance in illegal drugs is being expanded.
• China: China has played a significant role in the production and control of supply chain networks for this narcotic and its analogs within the global market. Recently, the Chinese government has made greater efforts to control the production and export of fentanyl products. In response to international pressure, China tightened regulations on this product while enacting law enforcement measures aimed at curbing illicit trafficking of fentanyl substances globally. Other endeavors also exist to address worldwide concerns surrounding synthetic opioids regarding public health and safety.
• Germany: Germany's steps toward increasing awareness about safe opioid use have seen some progress within their evolving fentanyl market. Recent developments include more controlled formulations of fentanyl, aimed at reducing addictive tendencies among users or abusers. Regulatory bodies in Germany are focusing on advocating for safe utilization mechanisms of these products, especially in cancer pain control. Among the various measures within Germany, there is a wider European initiative for collaborative regulation and public health to monitor and manage opioid use, including fentanyl.
• India: The fentanyl market in India is changing due to various problems associated with drug abuse (both medical and illicit). For instance, efforts have been made to strengthen regulations on the prescription and dispensing of fentanyl due to addiction concerns. The Indian government has embarked on tougher rules for opioids while improving drug enforcement systems. In addition, healthcare providers are being educated about fentanyl risks and patient monitoring behaviors that can reduce tendencies for misuse or dependence.
• Japan: The Japanese fentanyl market is characterized by stringent regulatory oversight and careful attitudes toward opioids. Notably, recent developments include the approval of new formulations of fentanyl designed for improved pain management with reduced addictive properties. Furthermore, efforts to intercept synthetic opioids before they reach the wrong hands have also intensified in Japan. Working closely with medical professionals, the government has sought ways to regulate fentanyl use among patients, thereby avoiding potential misuse or overdose incidents.

Features of the Global Fentanyl Market

Market Size Estimates: Fentanyl market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Fentanyl market size by route of administration, end use, and region in terms of value ($B).

Regional Analysis: Fentanyl market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different route of administration, end use, and regions for the fentanyl market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the fentanyl market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the fentanyl market by route of administration (sublingual tablet, buccal tablet, oral film, and others ), end use (hospital, oncology centers, surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Fentanyl Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Fentanyl Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Fentanyl Market by Route of Administration
  • 3.3.1: Sublingual Tablet
  • 3.3.2: Buccal Tablet
  • 3.3.3: Oral Film
  • 3.3.4: Others
• 3.4: Global Fentanyl Market by End Use
  • 3.4.1: Hospital
  • 3.4.2: Oncology Centers
  • 3.4.3: Surgical Centers
  • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Fentanyl Market by Region
• 4.2: North American Fentanyl Market
  • 4.2.1: North American Fentanyl Market by Route of Administration: Sublingual Tablet, Buccal Tablet, Oral Film, and Others
  • 4.2.2: North American Fentanyl Market by End Use: Hospital, Oncology Centers, Surgical Centers, and Others
• 4.3: European Fentanyl Market
  • 4.3.1: European Fentanyl Market by Route of Administration: Sublingual Tablet, Buccal Tablet, Oral Film, and Others
  • 4.3.2: European Fentanyl Market by End Use: Hospital, Oncology Centers, Surgical Centers, and Others
• 4.4: APAC Fentanyl Market
  • 4.4.1: APAC Fentanyl Market by Route of Administration: Sublingual Tablet, Buccal Tablet, Oral Film, and Others
  • 4.4.2: APAC Fentanyl Market by End Use: Hospital, Oncology Centers, Surgical Centers, and Others
• 4.5: ROW Fentanyl Market
  • 4.5.1: ROW Fentanyl Market by Route of Administration: Sublingual Tablet, Buccal Tablet, Oral Film, and Others
  • 4.5.2: ROW Fentanyl Market by End Use: Hospital, Oncology Centers, Surgical Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Fentanyl Market by Route of Administration
  • 6.1.2: Growth Opportunities for the Global Fentanyl Market by End Use
  • 6.1.3: Growth Opportunities for the Global Fentanyl Market by Region
• 6.2: Emerging Trends in the Global Fentanyl Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Fentanyl Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Fentanyl Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Bayer
• 7.2: Novartis
• 7.3: Sanofi-Aventis Groupe
• 7.4: Abbott Laboratories
• 7.5: Merck & Co
• 7.6: Validus Pharmaceuticals
• 7.7: Teva Pharmaceutical Industries